Plague Follow-up

Updated: Aug 15, 2017
  • Author: Venkat R Minnaganti, MD, FACP; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Follow-up

Transfer

Patients with plague who are critically ill and require transfer to another facility should be transported under strict isolation precautions.

Next:

Deterrence/Prevention

Prophylactic antibiotic therapy

The CDC recommends short-term prophylactic antibiotic therapy in people who have been bitten by potentially infected rodent fleas during a plague outbreak.

Prophylactic antibiotic therapy is recommended in persons who have handled an animal known to be infected with the plague bacterium.

Prophylactic antibiotic therapy is recommended in persons who have had close exposure to a person or an animal thought to have pneumonic plague. Sulfadoxine prophylaxis has been effective in outbreaks of pneumonic plague. [31] The infection rate in contacts was 8.4% with this strategy. Recent studies have shown that doxycycline can be used as an alternative for sulfadoxine. [30]

Preferred antibiotics for prophylaxis against plague include doxycycline 100 mg PO q12h for 14-21 days (for patients >8 y) or full-dose ciprofloxacin for 7 days. [32] Chloramphenicol may be used as an alternative. To be effective, chemoprophylaxis must be initiated within 7 days of exposure.

Plague vaccine

Plague vaccination is of limited use [33] and is not mandatory for entry into any country. The vaccine is not effective against the pneumonic form of plague. Plague vaccine is recommended for field workers in endemic areas and for scientists and laboratory personnel who routinely work with the plague bacterium. The vaccine is composed of killed whole cells. It needs to be taken as 2 injections 1-3 months apart followed by the booster every 6 months until the patient is no longer considered to be at risk. [19] Live vaccines are in development. [34]

Animal studies have conclusively established that certain antibodies are protective against plague. [35] Murine antibodies to fraction (FI) protein and/or fraction V antigen have been shown to be protective against bubonic and pneumonic plague in murine models. [36]

The F1-V (fusion protein) vaccine protected mice for a year against an inhalation challenge and is now being tested in primates. [32]

An oral vaccine with an attenuated strain of Y pseudotuberculosis named VTNF1 has been reported to provide highly efficient and long-lasting protection against both bubonic and pneumonic plague after a single oral vaccine dose. It confers full protection against the two forms of plague. This may offer an option for mass vaccination in tropical endemic areas, as well as for populations exposed to bioterrorism. [37]

Environmental sanitation

Efforts to control the animal reservoir and flea population may be effective in reducing transmission of plague bacteria.

Remove food sources used by rodents.

Rodent-proof homes, buildings, and warehouses.

Trained professionals should apply chemicals to kill fleas and rodents.

Trained professionals should fumigate cargo areas of ships and docks.

Previous
Next:

Complications

Potential complications of plague include the following:

Previous
Next:

Prognosis

Untreated plague carries a mortality rate of approximately 50%; however, with appropriate therapy, the mortality rate drops to approximately 5%. [38]

Previous
Next:

Patient Education

Report sick or dead animals to the local health department or law enforcement officials and wear gloves when handling potentially infected animals.

Eliminate food sources and nesting places for rodents around homes, workplaces, and recreation areas and make homes rodent-proof.

Personal protective measures include wearing protective clothing and applying insect repellents to clothing and skin to prevent flea bites.

Restrain pet dogs and cats in areas endemic to plague and regularly treat pets to control fleas.

Spraying of appropriate chemicals by health authorities may be necessary to kill fleas at selected sites during animal plague outbreaks.

Previous